PSPietro Spagnolo

Pietro Spagnolo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pietro Spagnolo has a total of 129 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • 4D Flow MRI ‐Based Quantification of Tricuspid Regurgitation: A Possible Approach to Improve Measurement Repeatability

    by Alessandra Riva, Giulia Pasqualin, Francesco Sturla, Lara Tondi, Simone Saitta, Davide Tondi, Jessica Zannoni, Giandomenico Disabato, Daniel Giese, Massimo Chessa, et al.

    Purpose: To address limitations in tricuspid regurgitation (TR) quantification by magnetic resonance imaging (MRI) or transthoracic echocardiography (TTE), a new method is proposed to directly quantify TR volume (TR V ) using 4D Flow MRI with retrospective tricuspid valve (TV) annular tracking. Methods: Thirty patients with TR were prospectively enrolled. TR V was quantified using four MRI‐based methods: (i) indirect, (ii) direct (2D phase‐contrast), (iii) 4D Flow with a static TV plane, and (iv) 4D Flow with dynamic annular tracking. Reproducibility and agreement were assessed in terms of TR grading against standard MRI‐ and TTE‐based methods. Results: The dynamic 4D Flow method correlated strongly with all other MRI methods ( r = 0.77–0.81, p < 0.0001) but consistently yielded higher TR V values. Compared with the indirect method, it showed a Bland–Altman bias of 16 mL (limits of agreement: −19 to 51 mL), along with the highest agreement (intraclass correlation coefficient of 0.88). Agreement in TR severity grading was poor across methods (kappa ≤ 0.07), with dynamic 4D Flow classifying more cases as moderate or severe. Agreement with TTE was slight (kappa = 0.17, p = 0.27) with concordant TR grading in 50% of patients. Inter‐observer reproducibility was excellent ( r = 0.99, bias = 0.7 mL, kappa = 0.80). Conclusion: 4D Flow with dynamic TV tracking offers a reproducible and potentially more sensitive method for TR V quantification than conventional MRI techniques. Despite limited alignment with TTE, this technique may help overcome key imaging limitations and improve TR clinical evaluation, especially in complex cases.

  • Prognostic role of myocardial storage, hypertrophy, and inflammation/fibrosis in Fabry cardiomyopathy: a new predictive score including T1 values

    by Antonia Camporeale, Gianluigi Guida, Maurizio Pieroni, Federico Pieruzzi, Paola Lusardi, Marta Ferraresi, Laura Econimo, Alessandro Burlina, Renzo Mignani, Francesca Graziani, et al.

    Aims: Limited data exist about the prognostic significance of the processes underlying Fabry Disease (FD) cardiomyopathy (storage, hypertrophy, inflammation/fibrosis) as detected by cardiac magnetic resonance (CMR). Notably, T1 mapping has had limited prognostic application primarily due to poor reproducibility across different sequences and vendors. This CMR study aimed to identify the prognostic weight of the different mechanisms of FD cardiomyopathy and to develop a predictive score of adverse cardiovascular (CV) events. Methods and results: This prospective, observational study enrolled 167 FD patients, who underwent CMR at baseline. The study endpoint was the composite of all-cause death, heart failure hospitalization, new-onset atrial fibrillation/flutter, non-sustained/sustained ventricular tachycardia, major bradyarrhythmias, and myocardial infarction with non-obstructive coronary arteries. Over a median follow-up of 40 months, 27 patients (16%) experienced the primary endpoint. Left ventricle mass index (LVMI) [HR 1.02 (1.02–1.03), P < 0.001], presence of late gadolinium enhancement (LGE) [HR 20.12 (6.02–67.24), P < 0.001] and its extent [number of LGE + segments: HR 1.51 (1.33–1.71), P < 0001], and septal T1 [HR 0.98 (0.97–0.99), <0.001], measured in both ShMOLLI and MOLLI sequences, were associated with the composite endpoint. None of the patients with normal T1 experienced adverse CV events. A multivariable model including age, LVMI, number of LGE+ segments, and T1 value showed a good performance in predicting the composite endpoint. Conclusion: We propose a 3-year prognostic score to predict CV outcome in FD, including age, LVMI, number of LGE+ segments, and septal T1. Normal T1 has a negative predictive value for adverse CV events irrespective of the acquisition setting.


  • Atypical Left Ventricular Remodeling in Fabry Cardiomyopathy: The Key Diagnostic Role of T1 Mapping

    by Stefano Censi, Giada De Angeli, Federico Pieruzzi, Lara Tondi, Gianluigi Guida, Giandomenico Disabato, Andrea Attanasio, Pietro Spagnolo, Gianpaolo Carrafiello, Massimo Lombardi, et al.

  • Dobutamine stress cardiac magnetic resonance role in patients with anomalous aortic origin of coronary arteries

    by Andrea Attanasio, Jessica Zannoni, Giandomenico Disabato, Gianluigi Guida, Lara Tondi, Antonia Camporeale, Antonio Rosato, Serena Anglese, Chiara Corrado, Mauro L Agnifili, et al.

    Aims: Anomalous Aortic Origin of Coronary Arteries (AAOCA) is associated with myocardial ischaemia and sudden cardiac death, particularly in young athletes. Although inducible myocardial ischaemia investigation is generally recommended, there is no clear indication of the most appropriate stress test, as the ECG exercise stress test presents low diagnostic accuracy. Dobutamine-stress cardiac magnetic resonance (dsCMR) has been proposed as a promising diagnostic tool, but its application has been limited to paediatric populations. This study aimed to evaluate the presence of inducible myocardial ischaemia assessed by dsCMR in AAOCA patients, regardless of age, and to identify factors associated with inducible myocardial ischaemia. Methods and results: In this single-centre observational study, 100 AAOCA patients who underwent dsCMR were enrolled from 2015 to 2024. dsCMR resulted positive in 14 cases, all showing perfusion abnormalities, with only one presenting segmental wall motion abnormalities. dsCMR was found to be safe without major adverse events. Factors significantly associated with inducible ischaemia included intramural course, the presence of ischaemic late gadolinium enhancement (LGE), and a history of acute coronary syndrome (ACS). Nine patients (9%) showed small areas of ischaemic LGE within the AAOCA territory, and they were older with a higher incidence of arterial hypertension, smoking habits and previous ACS episodes. Conclusion: dsCMR is a reliable test for the evaluation of myocardial ischaemia in AAOCA, especially for those with intramural course, ischaemic LGE, and previous ACS episodes. Although rare, older patients may have a myocardial ischaemic scar without alteration of ventricular function.


  • Open Access

    Can the Novel Photon-Counting CT Scan Accurately Predict Aortic Wall Thickness? Preliminary Results

    by Alessandra Sala, Carlo de Vincentiis, Francesco Grimaldi, Barbara Rubino, Manuela Cirami, Noemi Perillo, Renato Vitale, Rosanna Cardani, Sara Boveri, Michele Conti, et al.

    Background: Surgical indication of ascending thoracic aortic aneurysms (ATAA) is generally performed in prevention. Guidelines use aortic diameter as a predictor of rupture and dissection; however, this single parameter alone has a limited value in predicting the real-world risk of acute aortic syndromes. The novel photon-counting CT scan(pc-CT) is capable of better-analyzing tissue composition and aortic characterization. The aim of the study is to assess whether the correlation between aortic wall thickness measured with a pc-CT scan and histology exists. Methods: 14 Patients, with a mean age of 47 years, undergoing cardiac surgery for ATAA, who had preoperatively undergone a pc-CT scan, were retrospectively analyzed. Histology analyses of the resected aortic wall aneurysm were reviewed, and minimum/maximum measurements of intima+media of the aortic wall were performed. Radiology images were also examined, and aortic wall thickness measures were taken. Bland-Altman plots and Passing-Bablock regression analyses were conducted to evaluate the correlation between the values. Results: pc-CT scan mean measurements were 1.05 and 1.69 mm, minimum/maximum, respectively. Mean minimum/maximum histology measurements were 1.66 and 2.82 mm, respectively. Bland Altman plots and Passing-Bablock regression analyses showed the absence of systematic bias and confirmed that measurement values were sufficiently similar (minimum −0.61 [CI 95% 0.16–1.38]; maximum −1.1 [0.73–2.99]). Conclusions: Despite results being merely preliminary, our study shows encouraging sufficiently similar results between aortic wall thickness measurements made with pc-CT scan and histology analyses.


  • Open Access

    Comparative Analysis of Perivascular Adipose Tissue Attenuation on Chest Computed Tomography Angiography in Patients with Marfan Syndrome: A Case–Control Study

    by Domenico Tuttolomondo, Francesco Secchi, Nicola Gaibazzi, Nathasha Samali Udugampolage, Alessandro Pini, Massimo De Filippo, Pietro Spagnolo, Rosario Caruso, Jacopo Taurino

    Background: Marfan syndrome (MFS) is a rare autosomal dominant disorder affecting connective tissues due to mutations in the fibrillin-1 gene. These genetic changes often result in severe cardiovascular conditions, including asymptomatic thoracic aortic dilation potentially leading to dissection or rupture. Perivascular adipose tissue attenuation (PVAT) observed on computed tomography may serve as a marker of localized inflammation and indicate early histopathological changes in the vascular walls of MFS patients compared to healthy individuals. Objective: This study aimed to compare PVAT values between patients with MFS and healthy controls in order to explore whether MFS patients show higher PVAT secondary to these histopathological abnormalities. Methods: This case–control study assessed PVAT on ascending aorta through computed tomography angiography (CTA) in 54 genetically confirmed MFS patients and 43 controls with low ischemic risk, excluding those with known aortic aneurysms. Results: PVAT analysis revealed significant differences between the MFS patients and healthy controls (−70.6 HU [−72.6 HU to −68.5 HU] versus −75.1 HU [−77.1 HU to −73.1 HU], p = 0.002), suggesting potential early vascular changes in the MFS group. Conclusions: The findings underscore the potential diagnostic role of PVAT in patients with genetically confirmed MFS but normal ascending aorta diameter.


  • Cardiovascular magnetic resonance semi-automated threshold-based post-processing of right ventricular volumes in repaired tetralogy of Fallot

    by Lara Tondi, Stefano Figliozzi, Sara Boveri, Francesco Sturla, Giulia Pasqualin, Antonia Camporeale, Giandomenico Disabato, Andrea Attanasio, Gianpaolo Carrafiello, Pietro Spagnolo, et al.

    Background Cardiovascular magnetic resonance (CMR) is the gold-standard to estimate right ventricular (RV) volumes, which are key for clinical management of patients with repaired tetralogy of Fallot (rTOF). Semi-automated threshold-based methods (SAT) have been proposed for CMR post-processing as alternatives to fully manual standard tracing. We investigated the impact of SAT on RV analysis using different thresholds in rTOF patients. Methods RV volumes and mass were estimated using SAT and standard fully manual tracing methods in rTOF patients. Two threshold levels were set for SAT, i.e., default 50 (SAT-50) and 30 (SAT-30). RV stroke volumes (SV) were compared to main pulmonary artery forward flow (MPA-FF). Post-processing time, intra- and interobserver variabilities were compared across methods. Results Sixty-two CMRs of rTOF patients were analyzed. Compared to the standard fully manual tracing, no significant differences in RV mass, volumes and ejection fraction were observed using SAT-30, whereas SAT-50 significantly underestimated RV end-diastolic-volume index (EDVi) by 10.4% (mean difference of − 11.8 ± 6.2 ml/m2, p 0.03) and overestimated RV mass index by 21.8% (mean difference of 14.2 ± 11.9 g/m2, p 0.002). Compared to MPA-FF, RVSV by standard fully manual method and SAT-30 showed minor biases, respectively, 0.03 ml/m2 and 0.7 ml/m2, while SAT-50 underestimated RVSV by 6.86 ml/m2 (p < 0.001). In six patients, the degree of RV EDVi underestimation by SAT-50 determined a change of category from dilated to non-dilated RV. Intra- and interobserver variabilities were good to excellent for all methods. Post-processing duration was shorter for SAT compared to standard manual segmentation (5.5 ± 1.7 min vs. 19.5 ± 4.4 min, p < 0.001). Conclusion CMR SAT-30 post-processing is a precise, accurate and time-saving method for biventricular assessment of volumes, ejection fraction and mass in rTOF.


  • Open Access

    When Paying Attention Pays Back: Missense Mutation c.1006G>A p. (Val336Ile) in PRKAG2 Gene Causing Left Ventricular Hypertrophy and Conduction Abnormalities in a Caucasian Patient: Case Report and Literature Review

    by Emanuele Micaglio, Lara Tondi, Sara Benedetti, Maria Alessandra Schiavo, Antonia Camporeale, Giandomenico Disabato, Andrea Attanasio, Gianluigi Guida, Gianpaolo Carrafiello, Massimo Piepoli, et al.

    PRKAG2 cardiomyopathy is a rare genetic disorder that manifests early in life with an autosomal dominant inheritance pattern. It harbors left ventricular hypertrophy (LVH), ventricular pre-excitation and progressively worsening conduction system defects. Its estimated prevalence among patients with LVH ranges from 0.23 to about 1%, but it is likely an underdiagnosed condition. We report the association of the PRKAG2 missense variant c.1006G>A p. (Val336Ile) with LVH, conduction abnormalities (short PR interval and incomplete right bundle branch bock) and early-onset arterial hypertension (AH) in a 44-year-old Caucasian patient. While cardiac magnetic resonance (CMR) showed a mild hypertrophic phenotype with maximal wall thickness of 17 mm in absence of tissue alterations, the electric phenotype was relevant including brady–tachy syndrome and recurrent syncope. The same variant has been detected in the patient’s sister and daughter, with LVH + early-onset AH and electrocardiographic (ECG) alterations + lipothymic episodes, respectively. Paying close attention to the coexistence of LVH and ECG alterations in the proband has been helpful in directing genetic tests to exclude primary cardiomyopathy. Hence, identifying the genetic basis in the patient allowed for familial screening as well as a proper follow-up and therapeutic management of the affected members. A review of the PRKAG2 cardiomyopathy literature is provided alongside the case report.


  • Left atrial dysfunction predicts left ventricular remodelling in patients with preserved ejection fraction after acute ST-elevation myocardial infarction

    by Andrea Attanasio, Lara Tondi, Serenella Castelvecchio, Vittorio Pazzanese, Anna Palmisano, Antonio Esposito, Pietro Ameri, Claudia Canale, Alberto Cappelletti, Luca P Alberti, et al.

    Andrea Attanasio, Lara Tondi, Serenella Castelvecchio, Vittorio Pazzanese, Anna Palmisano, Antonio Esposito, Pietro Ameri, Claudia Canale, Alberto Cappelletti,


  • Top Cited Papers

    Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies

    by Alexis Elias Malavazos, Gianluca Iacobellis, Elena Dozio, Sara Basilico, Angelica Di Vincenzo, Carola Dubini, Lorenzo Menicanti, Elena Vianello, Chiara Meregalli, Chiara Ruocco, et al.

    Aims: Human epicardial adipose tissue (EAT) plays a crucial role in the development and progression of coronary artery disease, atrial fibrillation, and heart failure. Microscopically, EAT is composed of adipocytes, nerve tissues, inflammatory, stromovascular, and immune cells. Epicardial adipose tissue is a white adipose tissue, albeit it also has brown fat-like or beige fat-like features. No muscle fascia divides EAT and myocardium; this allows a direct interaction and crosstalk between the epicardial fat and the myocardium. Thus, it might be a therapeutic target for pharmaceutical compounds acting on G-protein–coupled receptors, such as those for glucose-dependent insulinotropic polypeptide (GIP), glucagon (GCG), and glucagon-like peptide-1 (GLP-1), whose selective stimulation with innovative drugs has demonstrated beneficial cardiovascular effects. The precise mechanism of these novel drugs and their tissue and cellular target(s) need to be better understood. We evaluate whether human EAT expresses GIP, GCG, and GLP-1 receptors and whether their presence is related to EAT transcriptome. We also investigated protein expression and cell-type localization specifically for GIP receptor (GIPR) and glucagon receptor (GCGR). Methods and results: Epicardial adipose tissue samples were collected from 33 patients affected by cardiovascular diseases undergoing open heart surgery (90.9% males, age 67.2 ± 10.5 years mean ± SD). Microarray and immunohistochemistry analyses were performed. Microarray analysis showed that GIPR and GCGR messenger ribonucleic acids (mRNAs) are expressed in EAT, beyond confirming the previously found GLP-1 [3776 ± 1377 arbitrary unit (A.U.), 17.77 ± 14.91 A.U., and 3.41 ± 2.27 A.U., respectively]. The immunohistochemical analysis consistently indicates that GIPR and GCGR are expressed in EAT, mainly in macrophages, isolated, and in crown-like structures. In contrast, only some mature adipocytes of different sizes showed cytoplasmic immunostaining, similar to endothelial cells and pericytes in the capillaries and pre-capillary vascular structures. Notably, EAT GIPR is statistically associated with the low expression of genes involved in free fatty acid (FFA) oxidation and transport and those promoting FFA biosynthesis and adipogenesis (P < 0.01). Epicardial adipose tissue GCGR, in turn, is related to genes involved in FFA transport, mitochondrial fatty acid oxidation, and white-to-brown adipocyte differentiation, in addition to genes involved in the reduction of fatty acid biosynthesis and adipogenesis (P < 0.01). Conclusions: Having reported the expression of the GLP-1 receptor previously, here, we showed that GIPR and GCGR similarly present at mRNA and protein levels in human EAT, particularly in macrophages and partially adipocytes, suggesting these G-protein–coupled receptors as pharmacological targets on the ongoing innovative drugs, which seem cardiometabolically healthy well beyond their effects on glucose and body weight.